S&P/TSX Composite Index Ends 0.13% Higher at 21227.87 — Data Talk
The S&P/TSX Composite Index is up 27.81 points or 0.13% today to 21227.87
--Up for four consecutive trading days
--Up 202.09 points or 0.96% over the last four trading days
--Largest four-day point and percentage gain since Wednesday, Jan. 24, 2024
--Longest winning streak since Tuesday, Jan. 23, 2024, when the market rose for four straight trading days
--Up eight of the past nine trading days
--Off 3.89% from its record close of 22087.22 hit Tuesday, March 29, 2022
--A new 52-week high
--Highest closing value since Thursday, April 21, 2022
--Up 13.29% from its 52-week low of 18737.39 hit Friday, Oct. 27, 2023
--Rose 2.22% from 52 weeks ago
--Up 2.57% from its 2024 closing low of 20695.02 hit Wednesday, Jan. 17, 2024
--Month-to-date it is up 1.29%
--Year-to-date it is up 269.43 points or 1.29%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
January 30, 2024 17:34 ET (22:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters